Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non–Small-cell Lung Cancer

2018144 citationsJournal Article

Authors

Good health and well-being

Published in: Clinical Lung Cancer

Volume 19, Issue 5, pp. 410-417.e1

Field-Weighted Citation Impact: 6.13